CGN Nuclear Technology Development Co., Ltd. (000881)

Overview

CGN Nuclear Technology Development Co., Ltd., originally known as China Dalian International Cooperation (Group) Holdings Ltd., rebranded in February 2017 and is headquartered in Shenzhen, China. Since its inception in 1993, the company has expanded its footprint extensively in the nuclear technology and material manufacturing sectors within China. It specializes in the production and sale of cable materials and industrial electron accelerators. Additionally, CGN Nuclear Technology delves into diverse sectors such as waste treatment technologies, new material development, healthcare, real estate development, and even maritime services, showcasing its multifaceted approach to industrial growth and technological implementation.

Products and Services

Industrial Electron Accelerators: CGN Nuclear Technology Development Co., Ltd. offers a range of accelerators including ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. These products find applications in various fields, such as flaw detection in materials and research in nanotechnology.

Electron Beam Waste Treatment: The company utilizes electron beam technology for the treatment of specialty wastes. This encompasses antibiotic residue treatment technology, pharmaceutical and chemical wastewater treatment, domestic sewage, and hazardous waste concentrate treatment services, aiming to provide sustainable and effective waste management solutions.

New Energy and Material Solutions: The provision of new energy solutions, elastomer materials, and synthetic materials such as modified polycarbonate, polyester, and polypropylene. Additionally, CGN offers continuous fiber reinforced thermoplastic composites and radiation resistant polypropylene, catering to the growing demand for advanced materials in various industries.

Healthcare Innovations: The company has ventured into the healthcare sector by providing proton therapy tumor system equipment, radioactive medical isotopes, and products for hospitals and nuclear medicine. This segment reflects the company’s commitment to combating serious health conditions through technological innovation.

Additional Ventures: Beyond its core offerings, CGN Nuclear Technology Development Co., Ltd. is engaged in the production and sale of plastics, real estate development, and also operates in irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction sectors. These diversified operations indicate the company’s broad business interests and its strategic approach to exploring new business avenues.